Recent Updates
Recently added Catalysts
ORIC Positive Sentiment Score: 70/100

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

Monday, November 25, 2024 1 min read
Key Takeaway: ORIC Pharmaceuticals, a clinical stage oncology company, announced its participation in two upcoming investor conferences in December 2024. Management will be involved in a fireside chat at the Evercore HEALTHCONx Conference on December 4 and a panel discussion at Citi’s Global Healthcare Conference on December 5. Webcasts of these discussions will be available on the company's website, extending engagement with investors and the public.

Market Sentiment Analysis

POSITIVE FACTORS

  • ORIC Pharmaceuticals is actively engaging with investors at major conferences.
  • Participation in investor conferences indicates growing interest in ORIC's oncology treatments.
  • Live webcasts will enhance transparency and accessibility for stakeholders.

Full Press Release Details

SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in December:
7th Annual Evercore HEALTHCONx Conference – Participating in a fireside chat on Wednesday, December 4, 2024, at 2:35 p.m. ET
Citi’s 2024 Global Healthcare Conference – Participating in the “Novel Mechanisms in Oncology II” panel on Thursday, December 5, 2024, at 11:00 a.m. ET
Live webcasts of the discussions will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcasts will be available for 90 days following the events.
About ORIC Pharmaceuticals, Inc.
Dominic Piscitelli, Chief Financial Officer
dominic.piscitelli@oricpharma.com

Frequently Asked Questions

When will ORIC Pharmaceuticals participate in the Evercore HEALTHCONx Conference?

ORIC Pharmaceuticals will participate in the Evercore HEALTHCONx Conference on December 4, 2024, at 2:35 p.m. ET.

What panel will ORIC Pharmaceuticals join at the Citi Conference?

ORIC Pharmaceuticals will join the 'Novel Mechanisms in Oncology II' panel on December 5, 2024, at 11:00 a.m. ET.

Where can I watch the live webcasts of ORIC's discussions?

Live webcasts of ORIC's discussions will be available in the investor section of their website.

How long will the webcasts be available for replay?

Replays of the webcasts will be available for 90 days after the events.

Who can I contact for more information about ORIC Pharmaceuticals?

For more information, you can contact Dominic Piscitelli at dominic.piscitelli@oricpharma.com.

Tags: ORIC Viatris Investor Conferences Healthcare oncology healthcare conferences investor engagement therapeutic resistance
Last updated: Nov 25, 2024